Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Identification of potential pathways and biomarkers linked to progression in ALS

Annals of Clinical and Translational Neurology(2022)10.1002/acn3.51697Source: DataRank Database

Identification of potential pathways and biomarkers linked to progression in ALS is a research paper published in Annals of Clinical and Translational Neurology (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 1.17)OA: goldTopics (54)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Swapnil Pandey ORCID,Deepak Chhangani ORCID,Diego E. Rincón-Limas ORCID,Nathan P. Staff ORCID,Crystal Jing Jing Yeo ORCID

Live enrichment

PubMed:36533811 PMC:PMC9930436 OpenAlex:https://openalex.org/W4311935221

National Institutes of Health

Grant: R01AG059871

National Institutes of Health

Grant: 1R01AG059871-01

Deconstructing and challenging TDP-43 proteinopathies: from FTLD/ALS to Alzheimer's disease

Agency for Science, Technology and Research

FWCI

1.17

Citation Percentile

0.8%

Citation Trend

2023

2024

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51697

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.51697

publisherhttps://onlinelibrary.wiley.com/doi/pdf/10.1002/acn3.51697

publisherhttps://onlinelibrary.wiley.com/doi/full-xml/10.1002/acn3.51697

journalhttps://doi.org/10.1002/acn3.51697

Fields of Study

Amyotrophic Lateral Sclerosis ResearchBioinformatics and Genomic NetworksNeurogenetic and Muscular Disorders Research0301 basic medicine0303 health sciences03 medical and health sciencesHumansAmyotrophic Lateral SclerosisBiomarkersDisease ProgressionMotor NeuronsPhenotypeMachine LearningDisease Models, AnimalDrosophilaInduced Pluripotent Stem CellsProteomics

MeSH Terms

Machine LearningAmyotrophic Lateral SclerosisDisease Models, AnimalDrosophilaHumansMotor NeuronsPhenotypeBiomarkersDisease ProgressionProteomicsInduced Pluripotent Stem Cells

Keywords

MedicineAmyotrophic lateral sclerosisBiomarkerProteomicsBiomarker discoveryBioinformaticsClinical trialOncologyComputational biologyDiseaseInternal medicineBiologyMotor NeuronsInduced Pluripotent Stem CellsNeurosciences. Biological psychiatry. NeuropsychiatryMachine LearningDisease Models, AnimalPhenotypeDisease ProgressionHumansDrosophilaNeurology. Diseases of the nervous systemRC346-429Research ArticlesBiomarkersRC321-571

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being